NORTHCOTT JOHN

Insider CIK 1615000 · LXRX VP, Marketing, Comm Strategy · NKTR SVP & Chief Commercial Officer

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
NKTR NEKTAR THERAPEUTICS	S Sale	2022-05-16	2022-05-17	4,592	$3.95	$18.1K	223,210	SEC↗
NKTR NEKTAR THERAPEUTICS	S Sale	2022-02-16	2022-02-18	4,852	$10.95	$53.1K	227,802	SEC↗
NKTR NEKTAR THERAPEUTICS	A Award deriv	2021-12-16	2021-12-20	67,150	—	$0	67,150	SEC↗
NKTR NEKTAR THERAPEUTICS	A Award	2021-12-16	2021-12-20	37,800	—	$0	232,654	SEC↗
NKTR NEKTAR THERAPEUTICS	S Sale	2021-11-16	2021-11-17	6,061	$13.16	$79.8K	194,854	SEC↗
NKTR NEKTAR THERAPEUTICS	S Sale	2021-08-16	2021-08-18	6,192	$13.83	$85.6K	200,915	SEC↗
NKTR NEKTAR THERAPEUTICS	S Sale	2021-05-17	2021-05-19	6,085	$18.30	$111.4K	207,107	SEC↗
NKTR NEKTAR THERAPEUTICS	S Sale	2021-02-16	2021-02-18	15,358	$22.37	$343.6K	213,192	SEC↗
NKTR NEKTAR THERAPEUTICS	A Award deriv	2020-12-18	2020-12-22	51,000	—	$0	51,000	SEC↗
NKTR NEKTAR THERAPEUTICS	A Award	2020-12-18	2020-12-22	28,550	—	$0	228,550	SEC↗
NKTR NEKTAR THERAPEUTICS	A Award deriv	2019-12-02	2019-12-04	200,000	—	$0	200,000	SEC↗
NKTR NEKTAR THERAPEUTICS	A Award	2019-12-02	2019-12-04	200,000	—	$0	200,000	SEC↗
LXRX LEXICON PHARMACEUTICALS, I	M Exercise deriv	2015-03-02	2015-03-03	11,250	—	$0	33,750	SEC↗
LXRX LEXICON PHARMACEUTICALS, I	F Tax w/h	2015-03-02	2015-03-03	3,015	$0.94	$2.8K	8,235	SEC↗
LXRX LEXICON PHARMACEUTICALS, I	M Exercise	2015-03-02	2015-03-03	11,250	—	$0	11,250	SEC↗
LXRX LEXICON PHARMACEUTICALS, I	A Award deriv	2015-02-05	2015-02-09	482,400	—	$0	482,400	SEC↗
LXRX LEXICON PHARMACEUTICALS, I	A Award deriv	2015-02-05	2015-02-09	120,600	—	$0	120,600	SEC↗